🔎 Trials Near Me

Home › Heart Failure › Louisiana › Monroe

Heart Failure clinical trials in Monroe, LA

5 studies for Heart Failure are looking for participants at sites in and around Monroe (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

RecruitingPhase 3
  • Research Site, West Monroe · 2 mi away
Ages 18 to 130 · All sexes · Updated Oct 2, 2026 · NCT06307652

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

RecruitingPhase 3
  • CON-10090, West Monroe, LA, West Monroe · 2 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

RecruitingPhase 3
  • West Monroe, LA Investigative Site 10090, West Monroe · 2 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

RecruitingPhase 3
  • Tenax Investigational Site, West Monroe · 2 mi away
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

RecruitingPhase 3
  • FIN-10090, West Monroe, LA, West Monroe · 2 mi away
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950

About Heart Failure

Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.

More about Heart Failure on MedlinePlus

Heart Failure trials in other cities

Other studies in Monroe

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.